Sign up to save your podcasts
Or
Share Filament Health with Tim Regan, Jesse Redmond and Ben Lightburn
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Filament Health with Tim Regan, Jesse Redmond and Ben Lightburn
Send us a text
Filament Health CEO Ben Lightburn joins WTR's Tim Regan and Jesse Redmond to discuss Filament's exclusive focus on naturally derived psychedelics and what sets it apart from other psychedelics drug developers. Lightburn reviews the characteristics of Filament's in-house drug development programs and talks about its expanding partnership network and the benefits it brings to the company. The podcast also covers the reasons behind the recently announced merger agreement with SPAC Jupiter Acquisition Corp.
View all episodes
By Water Tower Research
5
66 ratings
Send us a text
Filament Health CEO Ben Lightburn joins WTR's Tim Regan and Jesse Redmond to discuss Filament's exclusive focus on naturally derived psychedelics and what sets it apart from other psychedelics drug developers. Lightburn reviews the characteristics of Filament's in-house drug development programs and talks about its expanding partnership network and the benefits it brings to the company. The podcast also covers the reasons behind the recently announced merger agreement with SPAC Jupiter Acquisition Corp.
More shows like WTR Small-Cap Spotlight
View all
InvestTalk
1,512 Listeners
Motley Fool Money
3,189 Listeners
The Joe Rogan Experience
223,947 Listeners
a16z Podcast
1,000 Listeners
Money Tree Investing
645 Listeners
We Study Billionaires - The Investor’s Podcast Network
3,368 Listeners
Odd Lots
1,774 Listeners
Macro Voices
3,068 Listeners
Chit Chat Stocks
186 Listeners
The Cannabis Investing Podcast
206 Listeners
Value Hive Podcast
89 Listeners
The Prof G Pod with Scott Galloway
5,238 Listeners
Yet Another Value Podcast
101 Listeners
The Business Brew
245 Listeners
Plain English with Derek Thompson
2,147 Listeners